跳至主要内容
临床试验/NCT06965608
NCT06965608尚未招募不适用

Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers in Aparecida de Goiania (Brazil) - FLACC-Brazil

Hospital Israelita Albert Einstein1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2025年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,200
试验地点
1
主要终点
Feasibility of the WhatsApp-Based Intervention

研究概览

简要总结

Phase II non-randomized four-arm study (before/after pragmatic trial) that will test 2 different implementation strategies either combined or separately for the dissemination of the Latin America and the Caribbean Code Against Cancer within four different primary healthcare units in Aparecida de Goiânia.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (≥18 years old)
  • Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia
  • Healthcare professionals with at least three months of employment at a participating UBS
  • Ability to provide informed consent

排除标准

  • Prior diagnosis of any cancer or currently undergoing cancer treatment

结局指标

主要结局

Feasibility of the WhatsApp-Based Intervention

时间窗: Up to 2 weeks after WhatsApp intervention completion

Number of participants who report having read at least one WhatsApp message.

Acceptability of the WhatsApp-Based Intervention

时间窗: Up to 2 weeks after WhatsApp intervention completion

Mean acceptability score from participant survey (Likert scale 1-5) evaluating message usefulness and clarity.

Appropriateness of the WhatsApp-Based Intervention

时间窗: Up to 2 weeks after WhatsApp intervention completion

Proportion of participants who indicate willingness to receive similar messages in the future (Yes/No).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
2 期
Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive PatientsOvarian CancerFallopian Tube CancerPeritoneal Cavity Cancer
NCT01905163Centre Jean Perrin47
已完成
不适用
A Pragmatic Feasibility Trial to Promote Student Perspective-Taking on Client Physical Activity: A Collaborative ProjectCommunication
NCT06123507University of Manitoba163
终止
1 期
A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)B-Cell Chronic Lymphocytic Leukemia
NCT00302861Genitope Corporation86
终止
2 期
Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)Chronic Myeloid Leukemia
NCT00511121University of Bologna5
进行中(未招募)
1 期
A study with the aim to evaluate the antitumor activity of a new association of oral drugs, lenalidomide and clarithromycin in patients with lymphoma (MALT), when standard treatment with radiation therapy, chemotherapy and / or immunotherapy have shown a lack of efficacy.Patients with lymphoid tissue lymphoma mucosa-associated (MALT) for which the standard treatments with radiotherapy, chemotherapy and / or immunotherapy show lack of efficacy.MedDRA version: 21.0Level: PTClassification code 10015823Term: Extranodal marginal zone B-cell lymphoma (MALT type) recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10015824Term: Extranodal marginal zone B-cell lymphoma (MALT type) refractorySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2015-003168-35-ITIELSG - INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP68